Abstract
Background The incidence of myocardial infarction (MI) is rising among young individuals. This study aimed to identify the profile of standard modifiable risk factors (SMuRFs) and their impact on long-term survival in very young MI patients (≤35 years).
Methods The VYTAL-MI study (Very Young Tracking and Analysis of Long-term Myocardial Infarction Outcomes) is a retrospective cohort analysis of MI patients aged ≤35 years, admitted to Beijing Anzhen Hospital and Peking Union Medical College Hospital between December 11920, 2011, and December 11920, 2021. SMuRFs (hypertension, diabetes, hypercholesterolemia, smoking) were documented. The primary outcome was major adverse cardiovascular and cerebrovascular events (MACCE), including all-cause death, recurrent MI, ischemia-driven revascularization, and ischemic stroke. Cox proportional hazard models were used to assess associations between SMuRFs and outcomes.
Results Among 690 patients (median age 33 years [interquartile range, IQR: 30-34]; 95% male), only 8% had no SMuRFs. Smoking was most common (76%), followed by hypercholesterolemia (43%), hypertension (40%), and diabetes (12%). The most frequent combination was smoking and hypercholesterolemia (16.4%). Over a median follow-up of 6.3 years (IQR: 4.0-8.6), MACCE occurred in 165 patients (23.9%). Patients with ≥3 SMuRFs had significantly higher cumulative hazards (P=0.003). Hypertension (hazard ratio, HR: 1.50; 95% confidence interval, CI: 1.09-2.06; P=0.014) and diabetes (HR: 1.67; 95% CI: 1.10-2.54; P=0.016) were independently associated with increased risk, while hypercholesterolemia (HR: 1.24; 95% CI: 0.91-1.68; P=0.177) and smoking (HR: 1.06; 95% CI: 0.72-1.55; P=0.776) showed no significant association.
Conclusions Very young MI patients exhibited a high burden of SMuRFs, particularly smoking. Hypertension and diabetes increased long-term event risk. Targeted SMuRF management is essential to improve survival in this population.
What is known
Targeting standard modifiable cardiovascular risk factors, including hypertension, diabetes, hypercholesterolemia, and smoking, is crucial for improving outcomes in myocardial infarction.
Limited data exist on the pattern of standard modifiable risk factors in very young myocardial infarction patients aged ≤35 years, and how these factors influence long-term outcomes.
What the study adds
Very young myocardial infarction patients exhibited a substantial burden of standard modifiable risk factors, with smoking being notably prevalent.
Increased standard modifiable risk factors exposure was associated with an elevated risk of major adverse cardiovascular and cerebrovascular events
Hypertension and diabetes were linked to a higher risk of major adverse cardiovascular and cerebrovascular events, while smoking and hypercholesterolemia did not show a significant independent effect.
What the study addsRegistration: URL: http://www.chictr.org.cn; Unique identifier: ChiCTR2400085600.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
URL: http://www.chictr.org.cn; Unique identifier: ChiCTR2400085600
Funding Statement
National High-Level Hospital Clinical Research Funding (2022-PUMCH-C-024, 2022-PUMCH-B-030, 2022-PUMCH-A-241).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Ethics Committee of Beijing Anzhen Hospital, Capital Medical University, and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data supporting the findings of this study are available upon reasonable request. Interested researchers can contact the corresponding author via email at tangsiqi{at}pumch.cn.
Non-standard Abbreviations and Acronyms Abbreviation/Acronym Expanded Form
- ACE inhibitor
- Angiotensin-Converting Enzyme Inhibitor
- AFIJI
- Appraisal of Risk Factors in Young Ischemic Patients Justifying Aggressive Intervention
- ARB
- Angiotensin Receptor Blocker
- DDCD
- Duke Databank for Cardiovascular Disease
- GRS
- Genetic Risk Score
- MACCE
- Major Adverse Cardiovascular and Cerebrovascular Events
- PCSK9-i
- Proprotein convertase subtilisin/kexin type 9 inhibitor
- PDAY
- Pathobiological Determinants of Atherosclerosis in Youth
- SMuRF
- Standard Modifiable Risk Factor
